Beam Therapeutics Inc.

NASDAQ: BEAM · Real-Time Price · USD
17.11
-0.71 (-3.98%)
At close: Aug 18, 2025, 3:59 PM
17.11
0.00%
After-hours: Aug 18, 2025, 06:24 PM EDT

Beam Therapeutics Revenue

Beam Therapeutics reported an annual revenue of $63.52M, reflecting a -83.18% growth. For the quarter ending June 30, 2025, Beam Therapeutics generated $8.47M in revenue.
Revenue (ttm)
63.52M
Revenue Growth
-83.18%
Price / Sales Ratio
32.14
Revenue / Employee
161.62K
Employees
393
Market Cap
1.73B

Revenue Chart

Revenue History

Fiscal Year End Revenue % Change
Dec 31, 2024 63.52M -83.18%
Dec 31, 2023 377.71M +520.01%
Dec 31, 2022 60.92M +17.51%
Dec 31, 2021 51.84M +215916.67%
Dec 31, 2020 24K +33.33%
Dec 31, 2019 18K +Infinity%
Dec 31, 2018 0 n/a
Dec 31, 2017 0 n/a
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.